They are a direct legislative response to the failures of a rigid, patent-driven market, created to function within the inherent tension between the FDAs mission to ensure patient access and safety, and the patent systems mandate to protect and reward innovation
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist, not a GLP-1 receptor agonist
One of the most common is prior authorization, a process that requires your doctor to get pre-approval from the insurer
Patients who maintain regular physical activity, prioritize protein intake, and practice mindful eating during treatment are more likely to preserve weight loss after any treatment change
Discussing your specific reproductive timeline with both your weight loss provider and gynecologist ensures coordinated, personalized planning
doi: 10.1097/MOG.0000000000000934 97 UrdanetaVCasadessJ